These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4714551)

  • 21. [Growth hormone, insulin, glucemia and plasmatic free fatty acids after arginine administration (author's transl)].
    Portugal-Alvarez J; Enríquez L; Zamarrón A; Vila T; Catalá E; Velasco-Martín A
    Rev Esp Fisiol; 1973 Dec; 29(4):289-91. PubMed ID: 4791170
    [No Abstract]   [Full Text] [Related]  

  • 22. Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans.
    Broglio F; Gottero C; Prodam F; Destefanis S; Gauna C; Me E; Riganti F; Vivenza D; Rapa A; Martina V; Arvat E; Bona G; van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):503-9. PubMed ID: 15473884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The different responses of blood amino acids and blood glucose to the administration of insulin to patients with acromegaly.
    Zimmermann-Telschow H; Wiegelmann W; Solbach HG; Zimmermann H
    Horm Metab Res; 1973 Nov; 5(6):474-5. PubMed ID: 4767005
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of lipids on growth hormone secretion in humans.
    Blackard WG; Hull EW; Lopez A
    J Clin Invest; 1971 Jul; 50(7):1439-43. PubMed ID: 5090059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypolipidemic effects of metformin in hyperprebetalipoproteinemia.
    Fedele D; Tiengo A; Nosadini R; Marchiori E; Briani G; Garotti MC; Muggeo M
    Diabete Metab; 1976 Sep; 2(3):127-33. PubMed ID: 188698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma levels of insulin, free fatty acids and growth hormone: their relationship with carbohydrate metabolism in thyrotoxicosis].
    Ortigosa JL; Argote RM; García G; Cervantes C; Mendoza F; Parra A
    Arch Invest Med (Mex); 1975; 6(3):497-504. PubMed ID: 1190941
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
    Carpentier J; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1975 Mar; 1():23-8. PubMed ID: 1234063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].
    Descos L; M'Bendi S; Sassolas G; Audigier JC; Sidiqian N; Faure A; Bizollon CA
    Arch Fr Mal App Dig; 1974; 63(1):17-24. PubMed ID: 4441222
    [No Abstract]   [Full Text] [Related]  

  • 29. Dwarfism with elevated levels of plasma growth hormone.
    Najjar SS; Khachadurian AK; Ilbawi MN; Blizzard RM
    N Engl J Med; 1971 Apr; 284(15):809-12. PubMed ID: 5549802
    [No Abstract]   [Full Text] [Related]  

  • 30. Glucagon, insulin, cortisol, and growth hormone levels following major surgery: their relationship to glucose and free fatty acid elevations.
    Göschke H; Bär E; Girard J; Leutenegger A; Niederer W; Oberholzer M; Wolff G
    Horm Metab Res; 1978 Nov; 10(6):465-70. PubMed ID: 744565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of weight reduction on insulin responsiveness and triglyceride levels in patients with endogenous hypertriglyceridaemia.
    De Vries O; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):212-19. PubMed ID: 4465727
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of glucagon and of the glucose tolerance test on incretion of the somatotrophic hormone in normal subjects. Comparison of results].
    Giordano G; Marugo M; Minuto F; Barreca T
    Folia Endocrinol; 1971; 24(3):289-97. PubMed ID: 5171731
    [No Abstract]   [Full Text] [Related]  

  • 33. Growth hormone secretion after insulin stimulation in patients with chronic renal failure.
    Kokot F; Kuska J
    Pol Med J; 1972; 11(6):1439-45. PubMed ID: 4659068
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
    Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
    Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
    [No Abstract]   [Full Text] [Related]  

  • 35. Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with human growth hormone.
    Bonnet F; Vanderschueren-Lodeweyckx M; Eeckels R; Malvaux P
    Pediatr Res; 1974 Sep; 8(9):800-5. PubMed ID: 4370413
    [No Abstract]   [Full Text] [Related]  

  • 36. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
    Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term treatment of hyperlipidemic patients with clofibrate.
    Berkowitz D
    JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of halofenate on glucose tolerance in patients with hyperlipoproteinemia.
    Feldman EB; Gluck FB; Carter AC
    J Clin Pharmacol; 1978; 18(5-6):241-8. PubMed ID: 346616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between body composition and insulin and growth hormone responses in obese adolescents.
    Schultz RB; Parra A
    Diabetes; 1970 Jul; 19(7):492-501. PubMed ID: 5427553
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
    Eaton RP; Schade DS
    Metabolism; 1974 May; 23(5):445-54. PubMed ID: 4825301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.